Iterum Therapeutics (ITRM) to Release Quarterly Earnings on Friday

Iterum Therapeutics (NASDAQ:ITRM) will likely be issuing its quarterly earnings data before the market opens on Friday, February 7th. Analysts expect the company to announce earnings of ($0.26) per share for the quarter.

Iterum Therapeutics Price Performance

Shares of NASDAQ:ITRM opened at $1.54 on Tuesday. The company has a market capitalization of $42.37 million, a PE ratio of -0.77 and a beta of 2.33. Iterum Therapeutics has a 1-year low of $0.81 and a 1-year high of $3.02. The business has a fifty day moving average price of $1.85 and a 200-day moving average price of $1.43.

About Iterum Therapeutics

Iterum Therapeutics plc, a clinical-stage pharmaceutical company, engages in developing and commercializing anti-infectives in Ireland, Bermuda, and the United States. It is developing sulopenem, a novel anti-infective compound with oral and intravenous formulations that is in Phase III clinical trials for the treatment of uncomplicated urinary tract infections, complicated urinary tract infections, and complicated intra-abdominal infections.